Legend Biotech (LEGN) Interest Coverage Ratio (2019 - 2025)
Legend Biotech (LEGN) reported Interest Coverage Ratio of 3.58 for Q4 2025, down 76.51% on a YoY basis from 15.25 in Q4 2024, and down 53.54% quarter-over-quarter from 7.71 in Q3 2025.
Legend Biotech (LEGN) Interest Coverage Ratio (2019 - 2025) Analysis & Trends
Legend Biotech has reported Interest Coverage Ratio for 7 years, with the latest figure at 3.58 in Q4 2025.
- For the quarter ending Q4 2025, Interest Coverage Ratio fell 76.51% year-over-year to 3.58; the trailing twelve-month figure through Dec 2025 stood at 49.77 (down 49.16% YoY), and the FY2025 full-year result was 6.38, down 55.48% from the prior year.
- Interest Coverage Ratio for Q4 2025 stood at 3.58, down from 7.71 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 352716793.79 in Q1 2021, with the low at 13653625.55 in Q4 2023.
- Historically, Interest Coverage Ratio has averaged 16953023.6 across 5 years, with a median of 34.44 in 2023.
- Annual changes were most pronounced in 2021 — Interest Coverage Ratio jumped 2494405465.58% — and 2023, when it plunged 60752390.97%.
- Legend Biotech's Interest Coverage Ratio stood at 149.22 in 2021, then jumped by 84.94% to 22.47 in 2022, then sank by 60752390.97% to 13653625.55 in 2023, then jumped by 100.0% to 15.25 in 2024, then slumped by 76.51% to 3.58 in 2025.
- The last three Interest Coverage Ratio figures came in at 3.58 (Q4 2025), 7.71 (Q3 2025), and 64.71 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 49.84 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.58 |
| Sep 30, 2025 | 7.71 |
| Jun 30, 2025 | -64.71 |
| Mar 31, 2025 | 56.80 |
| Dec 31, 2024 | 15.25 |
| Sep 30, 2024 | 12.78 |
| Jun 30, 2024 | -55.51 |
| Mar 31, 2024 | 37.02 |
| Dec 31, 2023 | -13.65 Mn |
| Sep 30, 2023 | -35.04 |
| Jun 30, 2023 | -33.84 |
| Mar 31, 2023 | -24.54 |
| Dec 31, 2022 | -22.47 |
| Sep 30, 2022 | -41.95 |
| Jun 30, 2022 | -43.46 |
| Mar 31, 2022 | -117.76 |
| Dec 31, 2021 | -149.22 |
| Sep 30, 2021 | -391.68 |
| Jun 30, 2021 | -1,849.17 |
| Mar 31, 2021 | 352.72 Mn |